Plasma Lysophasphatidic Acid Level: A Diagnostic Tool and Benchmark for Ovarian Cancer Management
Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 5
Abstract
In ovarian cancer there is formation of tumor cells in ovarian tissues. Lysophosphatidic acid (LPA) motivated cell proliferation, migration and endurance by acting on its cognate G-protein-coupled receptors. Lysophosphatidic acid (LPA), present in ascitic fluid, motivates the enlargement of malignant ovarian tumors by raising the appearance of vascular endothelial growth factor (VEGF) in ovarian cancer cells. Ovarian cancer cell progress is repressed by alendronate, a nitrogen containing biophosphate which attenuate the establishment of Rho by blocking the mevalonate pathway. In ovarian cancer there is formation of tumor cells in ovarian tissues. In the US, in about 69 women 1 woman will build up this malignancy during her life span. And, not only this disease occurs in women over the age of 50 but also in women with younger ages [1]. There are many different types of ovarian tumors. Few of them comprise: Ovarian (it is mainly extensive type of ovarian tumor), Ovarian germ cell tumor and Low malignant potential ovarian tumor [2]. Plasma LPA levels may demonstrate that it is a potential biomarker for ovarian cancer and other gynecologic cancers [3]. Significantly high total LPA levels were resolute in the sera of patients with diverse types of tumors benevolent (benign) and wicked (malignant) [4]. Lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and sphingosine-1-phosphate (S1P) appear useful as investigative and predictive biomarkers of ovarian cancer [5].
Authors and Affiliations
Muhammad Imran Qadir, Saima Saadat
Keywords
Related Articles
- EP ID EP587867
- DOI 10.32474/OAJOM.2018.01.000122
- Views 76
- Downloads 0
Acute Erythroblastic Leukemia Revealed by Dermatological Manifestations
Acute erythroblastic leukemia is characterized by the proliferation of a predominant erythrocyte population on other lineages. Cutaneous manifestations remain rare and misleading, making the diagnosis of difficult to sus...
Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection
Somatic mutations have been perceived as the causal event in the origin of the vast majority of cancers. Advanced massively parallel, highthroughput DNA sequencing have enabled the comprehensive characterization of somat...
Benign Metastasizing Leiomyoma and Intravenous Leiomyomatosis Following Total Hysterectomy: Two Case Reports and a Literature Review
Uterine leiomyomas are the most common gynecological tumor in women of reproductive age. These tumors are typically benign entities, but uncommonly transition toward tissues of malignant potential. Rare growth patterns o...
Re-Purposing Evodiamine as an Anti-Cancer Drug: Effects on Migration and Apoptosis
Introduction: Evodiamine is a quinolone alkaloid compound obtained from a fruit described in traditional Chinese medicine. It has been in use for many centuries for the treatment of headaches, menstrual problems, abdomin...
Repurposed Drugs and Nutraceutical Supplements as Neglected Complements to Cancer Treatment
In ovarian cancer there is formation of tumor cells in ovarian tissues. Lysophosphatidic acid (LPA) motivated cell proliferation, migration and endurance by acting on its cognate G-protein-coupled receptors. Lysophosphat...